Artificial intelligence assessment of the potential of tocilizumab along with corticosteroids therapy for the management of COVID-19 evoked acute respiratory distress syndrome.
Acute respiratory distress syndrome (ARDS), associated with high mortality rate, affects up to Dugouts 67% of hospitalized COVID-19 patients.Early evidence indicated that the pathogenesis of COVID-19 evoked ARDS is, at least partially, mediated by hyperinflammatory cytokine storm in which interleukin 6 (IL-6) plays an essential role.The corticoster